Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M De Hert

Showing results (61-70 of 95) with videos related to

Pageof 10
Sort By:
Clinical Practice and Epidemiology in Mental Health : CP & EMH|June 29, 2006
Prevalence of diabetes, metabolic syndrome and metabolic abnormalities in schizophrenia over the course of the illness: a cross-sectional studyM De Hert, R van Winkel, D Van Eyck, et al.
American Journal of Medical Genetics|December 15, 1994
Study of the possible association of HLA class II, CD4, and CD3 polymorphisms with schizophreniaM G Zamani, M De Hert, M Spaepen, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|February 19, 2013
Dysmetabolic features of the overweight patients receiving antipsychotic drugs: a comparison with normal weight and obese subjectsP Manu, C-U Correll, M Wampers, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|June 15, 2010
Second-generation antipsychotics and constipation: a review of the literatureM De Hert, H Hudyana, L Dockx, et al.
Revue Medicale De Liege|August 2, 2008
[Brain in the core of metabolic regulations: disorders in schizophrenic patients treated with atypical antipsychotics]L Hanssens, A J Scheen, R van Winkel, et al.
Tijdschrift Voor Psychiatrie|March 16, 2011
[Clinical assessment of the ultra high risk of developing a a psychotic disorder; review and critical reflection]K Lacluyse, L van Bouwel, H Demunter, et al.
International Journal of Psychiatry in Clinical Practice|June 17, 2014
Belgian consensus on metabolic problems associated with atypical antipsychoticsA De Nayer, M De Hert, A Scheen, et al.
Tijdschrift Voor Psychiatrie|January 3, 2025
[The usefulness of therapeutic drug monitoring during treatment with second-generation antidepressants]K Catthoor, G Steegen, M De Hert, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|October 16, 2010
M De Hert, J M Dekker, D Wood, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|August 18, 2009
Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC)M De Hert, J M Dekker, D Wood, et al.
Pageof 10

Showing results (61-70 of 95) with videos related to

Sort By:
Pageof 10
Clinical Practice and Epidemiology in Mental Health : CP & EMH|June 29, 2006
Prevalence of diabetes, metabolic syndrome and metabolic abnormalities in schizophrenia over the course of the illness: a cross-sectional studyM De Hert, R van Winkel, D Van Eyck, et al.
American Journal of Medical Genetics|December 15, 1994
Study of the possible association of HLA class II, CD4, and CD3 polymorphisms with schizophreniaM G Zamani, M De Hert, M Spaepen, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|February 19, 2013
Dysmetabolic features of the overweight patients receiving antipsychotic drugs: a comparison with normal weight and obese subjectsP Manu, C-U Correll, M Wampers, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|June 15, 2010
Second-generation antipsychotics and constipation: a review of the literatureM De Hert, H Hudyana, L Dockx, et al.
Revue Medicale De Liege|August 2, 2008
[Brain in the core of metabolic regulations: disorders in schizophrenic patients treated with atypical antipsychotics]L Hanssens, A J Scheen, R van Winkel, et al.
Tijdschrift Voor Psychiatrie|March 16, 2011
[Clinical assessment of the ultra high risk of developing a a psychotic disorder; review and critical reflection]K Lacluyse, L van Bouwel, H Demunter, et al.
International Journal of Psychiatry in Clinical Practice|June 17, 2014
Belgian consensus on metabolic problems associated with atypical antipsychoticsA De Nayer, M De Hert, A Scheen, et al.
Tijdschrift Voor Psychiatrie|January 3, 2025
[The usefulness of therapeutic drug monitoring during treatment with second-generation antidepressants]K Catthoor, G Steegen, M De Hert, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|October 16, 2010
M De Hert, J M Dekker, D Wood, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|August 18, 2009
Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC)M De Hert, J M Dekker, D Wood, et al.
Pageof 10